Cargando...
Targeted Therapy for Medullary Thyroid Cancer: A Review
Medullary thyroid cancers (MTCs) constitute between 2 and 5% of all thyroid cancers. The 10-year overall survival (OS) rate of patients with localized disease is around 95% while that of patients with regional stage disease is about 75%. Only 20% of patients with distant metastases at diagnosis surv...
Guardado en:
| Publicado en: | Front Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635342/ https://ncbi.nlm.nih.gov/pubmed/29057215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00238 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|